Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brough

Showing results (681-690 of 871) with videos related to

Pageof 88
Sort By:
AIDS and Behavior|October 7, 2020
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives StudyPatricia de Los Rios, Chinyere Okoli, Erika Castellanos, et al.
Vaccine|January 24, 2018
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccineJosé Barrera, Christopher Schutta, Melia Pisano, et al.
Age and Ageing|April 10, 2025
Factors influencing fall prevention programmes across three regions of the UK: the challenge of implementing and spreading the Falls Management Exercise (FaME) programme in a complex landscapeJodi P Ventre, Fay Manning, Aseel Mahmoud, et al.
Journal of the American Academy of Dermatology|July 26, 2015
Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014Stanislav N Tolkachjov, Aodhnait S Fahy, David A Wetter, et al.
BMJ Open|September 24, 2020
Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort studyCarlo Berzuini, Cathal Hannan, Andrew King, et al.
Developments in Biologicals|August 15, 2012
Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testingD A Brake, M McIlhaney, T Miller, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2012
The discovery of CCR3/H1 dual antagonists with reduced hERG riskAsh Bahl, Patrick Barton, Keith Bowers, et al.
Stem Cells (Dayton, Ohio)|June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancersAnna L Stratford, Kristen Reipas, Kaiji Hu, et al.
BMC Veterinary Research|August 31, 2018
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission modelJohn G Neilan, Christopher Schutta, José Barrera, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 16, 2023
Structured group education programme and accompanying mHealth intervention to promote physical activity in women with a history of gestational diabetes: A randomised controlled trialKamlesh Khunti, Nithya Sukumar, Ghazala Waheed, et al.
Pageof 88

Showing results (681-690 of 871) with videos related to

Sort By:
Pageof 88
AIDS and Behavior|October 7, 2020
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives StudyPatricia de Los Rios, Chinyere Okoli, Erika Castellanos, et al.
Vaccine|January 24, 2018
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccineJosé Barrera, Christopher Schutta, Melia Pisano, et al.
Age and Ageing|April 10, 2025
Factors influencing fall prevention programmes across three regions of the UK: the challenge of implementing and spreading the Falls Management Exercise (FaME) programme in a complex landscapeJodi P Ventre, Fay Manning, Aseel Mahmoud, et al.
Journal of the American Academy of Dermatology|July 26, 2015
Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014Stanislav N Tolkachjov, Aodhnait S Fahy, David A Wetter, et al.
BMJ Open|September 24, 2020
Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort studyCarlo Berzuini, Cathal Hannan, Andrew King, et al.
Developments in Biologicals|August 15, 2012
Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testingD A Brake, M McIlhaney, T Miller, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2012
The discovery of CCR3/H1 dual antagonists with reduced hERG riskAsh Bahl, Patrick Barton, Keith Bowers, et al.
Stem Cells (Dayton, Ohio)|June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancersAnna L Stratford, Kristen Reipas, Kaiji Hu, et al.
BMC Veterinary Research|August 31, 2018
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission modelJohn G Neilan, Christopher Schutta, José Barrera, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 16, 2023
Structured group education programme and accompanying mHealth intervention to promote physical activity in women with a history of gestational diabetes: A randomised controlled trialKamlesh Khunti, Nithya Sukumar, Ghazala Waheed, et al.
Pageof 88